Imerys Quote - NK

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

32.68

Bid

32.56

Offer

33.00

Volume

29,782

32.56 Day's Range 33.04

25.54 52 Week Range 38.50

Market Cap

2.757B

Previous Close

33.16

Open

32.92

Last Trade

121

32.68

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

96,943

Shares Outstanding

84,367,933

Dividend Yield

4.13%

PE Ratio

-29.02

Earnings Per Share (EPS)

-1.13

Revenue

3.64B

Net Profit

-95M

Sector

Minrls,earths-ground,treated

Industry

Structural Clay Products

Website

www.imerys.com

Headquarters

Paris, Paris, Fra

Founded

1880

Imerys is listed in the Minrls,earths-ground,treated sector of the Euronext with ticker NK. The last closing price for Imerys was 33.16 €. Over the last year, Imerys shares have traded in a share price range of 25.54 € to 38.50 €.

Imerys currently has 84,367,933 shares in issue. The market capitalisation of Imerys is 2.80 € billion. Imerys has a price to earnings ratio (PE ratio) of -29.02.

J&J Opposes Former Talc Supplier's Bankruptcy Plan to Resolve Cancer Claims

By Peg Brickley Imerys SA is pressing ahead in an effort to get out from under lawsuits over its U.S. mining operation, Imerys Talc America Inc...

Imerys Unit Proposes Bankruptcy Plan to Resolve Cancer Lawsuits

By Peg Brickley France-based Imerys SA is offering to sell a bankrupt North American unit that was historically a major supplier of talc to...

J&J Loses Suit Tying Cancer To Baby Powder -- WSJ

By Anne Steele and Jonathan D. Rockoff Johnson & Johnson was hit with a $110 million jury decision in favor of a woman who said talc in the...

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case -- 2nd Update

By Anne Steele and Jonathan D. Rockoff Johnson & Johnson was hit with a $110 million jury decision in favor of a woman who said talc in the...

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case -- Update

By Anne Steele and Jonathan D. Rockoff Johnson & Johnson was hit with a $110 million jury decision in favor of a woman who said talc in the...

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case

By Anne Steele Johnson & Johnson was hit with a $110 million jury decision in favor of a woman who said talc in the company's baby powder...

AMCOL Approves Sweetened Bid From Imerys

AMCOL International Corp. has approved an amended takeover offer from Imerys worth $45.25 per share, narrowly topping a rival bid and again...

Minerals Technologies Boosts Bid for AMCOL

Minerals Technologies Inc. boosted its bid for AMCOL International Corp. to $45 a share, topping a recently sweetened bid from Imerys and raising...

AMCOL Board Approves Sweetened Bid From Imerys

AMCOL International Corp. said its board unanimously approved a sweetened takeover offer from Imerys worth $42.75 a share, topping a recent...

Acquisition of AMCOL International Corporation by Imerys S.A. May Not Be in Shareholders' Best Interests

Acquisition of AMCOL International Corporation by Imerys S.A. May Not Be in Shareholders' Best Interests PR Newswire SAN DIEGO and HOFFMAN...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.38	1.17647058824	32.3	33.32	31.28	55156	32.25281717	DE
4	4.54	16.1336176262	28.14	34.54	27.32	127530	30.94179095	DE
12	4.88	17.5539568345	27.8	34.54	25.54	96943	29.15253807	DE
26	2.06	6.72762900065	30.62	34.54	25.54	88157	29.2051198	DE
52	2.8	9.37081659973	29.88	38.5	25.54	84981	31.05578987	DE
156	-7.68	-19.028741328	40.36	43.22	23.2	83874	32.64046106	DE
260	9.74	42.4585876199	22.94	46.82	20.9	89838	33.83552985	DE

NK - Frequently Asked Questions (FAQ)

What is the current Imerys share price?

The current share price of Imerys is 32.68 €

How many Imerys shares are in issue?

Imerys has 84,367,933 shares in issue

What is the market cap of Imerys?

The market capitalisation of Imerys is EUR 2.8B

What is the 1 year trading range for Imerys share price?

Imerys has traded in the range of 25.54 € to 38.50 € during the past year

What is the PE ratio of Imerys?

The price to earnings ratio of Imerys is -29.02

What is the cash to sales ratio of Imerys?

The cash to sales ratio of Imerys is 0.76

What is the reporting currency for Imerys?

Imerys reports financial results in EUR

What is the latest annual turnover for Imerys?

The latest annual turnover of Imerys is EUR 3.64B

What is the latest annual profit for Imerys?

The latest annual profit of Imerys is EUR -95M

What is the registered address of Imerys?

The registered address for Imerys is 43, QUAI DE GRENELLE, PARIS, PARIS, 75015

What is the Imerys website address?

The website address for Imerys is www.imerys.com

Which industry sector does Imerys operate in?

Imerys operates in the STRUCTURAL CLAY PRODUCTS sector

Symbol	Price	Vol.
PHXMPHAXIAM Therapeutics SA	1.378 € (344.52%)	586.21k
ALCYBCybergun	0.0002 € (100.00%)	154.55M
ESONEstoril Sol	4.80 € (22.45%)	10
ALINSIntrasense	0.298 € (21.63%)	1.39M
MHMMyHotelMatch	0.451 € (21.56%)	46.04k
ARVBSArverne Group	0.0515 € (-48.50%)	9.84k
MLCOTCoretech 5	0.035 € (-31.37%)	50k
ALHAFHaffner Energy SA	0.675 € (-24.16%)	151.81k
PARROParrot	7.90 € (-15.60%)	135.23k
SIFGSif Holding NV	10.22 € (-14.69%)	471.12k
ATOAtos SE	0.0037 € (-2.63%)	699.98M
ALCYBCybergun	0.0002 € (100.00%)	154.55M
ALEUPEuroplasma	0.0128 € (-3.76%)	82.63M
BCPBanco Comercial Portugues SA	0.577 € (-0.17%)	59.1M
ALHPIHopium SA	0.0019 € (-5.00%)	31.34M

Symbol

Price

Vol.

ATOAtos SE

0.0037 €

(-2.63%)

699.98M

ALCYBCybergun

0.0002 €

(100.00%)

154.55M

ALEUPEuroplasma

0.0128 €

(-3.76%)

82.63M

BCPBanco Comercial Portugues SA

0.577 €

(-0.17%)

59.1M

ALHPIHopium SA

0.0019 €

(-5.00%)

31.34M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Imerys (NK)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

About Imerys

Ask ADVFN Intelligence (AI)

NK Latest News

J&J Opposes Former Talc Supplier's Bankruptcy Plan to Resolve Cancer Claims

Imerys Unit Proposes Bankruptcy Plan to Resolve Cancer Lawsuits

J&J Loses Suit Tying Cancer To Baby Powder -- WSJ

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case -- 2nd Update

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case -- Update

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case

AMCOL Approves Sweetened Bid From Imerys

Minerals Technologies Boosts Bid for AMCOL

AMCOL Board Approves Sweetened Bid From Imerys

Acquisition of AMCOL International Corporation by Imerys S.A. May Not Be in Shareholders' Best Interests

NK - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Imerys (NK) Share Price

Imerys (NK)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

About Imerys

Ask ADVFN Intelligence (AI)

NK Latest News

J&J Opposes Former Talc Supplier's Bankruptcy Plan to Resolve Cancer Claims

Imerys Unit Proposes Bankruptcy Plan to Resolve Cancer Lawsuits

J&J Loses Suit Tying Cancer To Baby Powder -- WSJ

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case -- 2nd Update

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case -- Update

Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case

AMCOL Approves Sweetened Bid From Imerys

Minerals Technologies Boosts Bid for AMCOL

AMCOL Board Approves Sweetened Bid From Imerys

Acquisition of AMCOL International Corporation by Imerys S.A. May Not Be in Shareholders' Best Interests

NK - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free